Investment Case

Sparta AG published the offer document for the takeover bid to the shareholders of 4basebio AG for the acquisition of the no-par value registered shares of 4basebio AG (ISIN DE000A2YN801…

4basebio AG announces process for spin-off and separate stock market listing for its DNA business Following a strategic review, 4basebio AG announced on 17 August 2020 its intention to commence…

– 4basebio: a manufacturer of pharmaceutical grade DNA
– New manufacturing processes
– Pursueing vertical integration for gene therapy and DNA vaccines

25 August 2020: First Berlin, Analyst Christian Orquera – Update note after H1 2020 financial results 15 July 2020: First Berlin, Analyst Christian Orquera –  “AIMING TO DISRUPT THE DNA…